A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients

Abstract : Some bacterial species recovered from the airways of cystic fibrosis (CF) patients are indisputably associated with lung infections, whereas the clinical relevance of others, such as Nocardia spp., remains unclear. Sixteen French CF cases of colonization/infection with Nocardia spp. were reviewed in order to evaluate the epidemiology, the clinical impact and the potential treatment of these bacteria, and results were compared to those of the literature. Five Nocardia species were identified, Nocardia cyriacigeorgica being the major species (50 % of cases). At first isolation, Nocardia was the sole pathogen recovered in six patients. Seven patients presented pulmonary exacerbation. For 12 patients, antimicrobial treatment against Nocardia was started immediately, mainly based on cotrimoxazole (6 of the 12 cases). In this study, we highlight the heterogeneity of the clinical management of Nocardia spp. in CF. Guidelines for the clinical management of Nocardia infections in CF patients are proposed.
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-02190950
Contributeur : Cécile Nowak <>
Soumis le : mardi 23 juillet 2019 - 10:38:00
Dernière modification le : mercredi 24 juillet 2019 - 01:20:56

Identifiants

Citation

Véronica Rodriguez-Nava, Stéphane Durupt, Sandra Chyderiotis, Anne-Marie Freydiere, Judith Karsenty, et al.. A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients. Medical Microbiology and Immunology, Springer Verlag, 2015, 204 (4), pp.493-504. ⟨10.1007/s00430-014-0360-3⟩. ⟨hal-02190950⟩

Partager

Métriques

Consultations de la notice

14